Graviton Bioscience


Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.

Employees

11-50

Links


Org chart

Samuel Waksal
Chief Executive Officer
Collapse
Robert Jan Lamers
Managing Director
Emmanuelle Zaoui
Vice President Of AI & Operations
Julia Balanova
Vp, Corporate Strategy And Communications
Christie Matsui
Chief People Officer
Amy Melsaether
Chief Medical Officer